Controls | COPD | |
TNF-308 | ||
Patients n | 86 | 63 |
Genotype | ||
1,1 | 72 (0.84) | 54 (0.86) |
1,2 | 14 (0.16) | 9 (0.14) |
2,2 | 0 | 0 |
Allele | ||
TNF-308*1 | 158 (0.92) | 117 (0.93) |
TNF-308*2 | 14 (0.08) | 9 (0.07) |
LtαNcoI | ||
Patients n | 85 | 59 |
Genotype | ||
1,1 | 4 (0.05) | 1 (0.02) |
1,2 | 34 (0.4) | 18 (0.3) |
2,2 | 47 (0.55) | 40 (0.68) |
Allele | ||
LtαNcoI*1 | 42 (0.25) | 20 (0.17) |
LtαNcoI*2 | 128 (0.75) | 98 (0.83) |
Data are presented as frequency (%)
COPD: chronic obstructive pulmonary disease
One subject among controls and four subjects among COPD were not typed for LtαNcoI because of insufficient deoxyribonucleic acid
All comparisons were nonsignificant